Skip to main content

Table 1 Baseline characteristics of participants in KM2H2 program

From: Persistent effect at 30-month post intervention of a community-based randomized trial of KM2H2 in reducing stroke and heart attack among senior hypertensive patients

Characteristic Total Intervention Control p value
Sample size 450 232 218  
Age in years, n (%) 0.662
 55–59 years 119 (26.4) 53 (22.8) 66 (30.3)  
 60–64 years 136 (30.2) 76 (32.8) 60 (27.5)  
 65–69 years 111 (24.7) 66 (28.4) 45 (20.6)  
 70+ years 84 (18.7) 37 (16.0) 47 (21.6)  
 Mean (SD) 64.2 (6.1) 64.3(5.6) 64.0 (6.5)  
Gender, n (%) 0.625
 Male 189 (42.0) 100 (43.1) 89 (40.8)  
 Female 261 (58.0) 132 (56.9) 129 (59.2)  
Monthly personal income RMB, n (%) 0.001
 <1000 Yuan 94 (20.9) 42 (9.3) 52 (23.8)  
 1000–2499 Yuan 234 (52.0) 111 (47.8) 123 (56.4)  
 ≥2500 Yuan 115 (25.6) 77 (33.2) 38 (17.4)  
 Unknown 7 (0.9) 2 (0.9) 5 (2.3)  
Marital status, n (%) 0.002
 Married/cohabit 398 (88.4) 216 (93.1) 182 (83.5)  
 Divorced/separated 36 (8.0) 10 (4.3) 26 (11.9)  
 Not reported 16 (3.6) 6 (2.6) 10 (4.6)  
Regular smoking, n (%) 0.004
 Yes 85 (18.9) 32 (13.8) 53 (24.3)  
 No 365 (81.1) 200 (86.2) 165 (75.7)  
Regular drinking, n (%) 0.952
 Yes 80 (17.8) 41 (17.7) 39 (17.9)  
 No 370 (82.2) 191 (82.3) 179 (82.1)  
Blood pressure (mmHg)
 Systolic, mean (SD) 141.2 (17.2) 140.7 (17.1) 141.7 (17.3) 0.565
 Diastolic, mean (SD) 86.5 (10.8) 86.1(9.3) 87.0 (12.3) 0.399
Years of hypertension, n (%) 0.021
 <5 years 143 (31.8) 61 (26.3) 82 (37.6)  
 5–14 years 184 (40.9) 98 (42.2) 86 (39.5)  
 ≥15 years 123 (27.3) 73 (31.5) 50 (22.9)  
 Mean (SD) 12.5 (10.7) 13.0 (10.5) 12.0 (10.9)  
Family history, n (%)
 Hypertension 264 (58.7) 141 (60.8) 123 (56.4) 0.349
 Diabetes 48 (10.7) 25 (10.8) 23 (10.6) 0.938
 Stroke 68 (15.1) 41 (17.7) 27 (12.4) 0.118
 Heart diseases 52 (11.6) 32 (13.8) 20 (9.2) 0.126
 Hyperlipidemia 34 (7.6) 16 (6.9) 18 (8.3) 0.585
Medication adherence, n (%) 314 (69.8) 161 (69. 4) 153 (70.2) 0.856
  1. Note: SD standard error